Inside Innovation

University of Washington biochemist and Nobel Prize winner David Baker said he remains committed to staying in Seattle so he can focus on the work

Omeros reported stronger-than-expected fourth quarter results, driven primarily by its partnership with Novo Nordisk for rare disease therapy zaltenibart. The company posted $86.5 million in

Immusoft received a $15 million grant from the California Institute for Regenerative Medicine to support clinical development of its engineered B cell therapy, ISP-001, for

The Health Sciences and Services Authority (HSSA) of Spokane awarded $3.25 million in grants to five bioscience and health companies to support research, development, and

Researchers from the Tapscott lab identified KHDC1L as a circulating biomarker for DUX4 activity in facioscapulohumeral muscular dystrophy. Facioscapulohumeral muscular dystrophy is driven by abnormal

Seattle’s life sciences market remains stable despite declines in federal and venture funding, according to Colliers’ 2026 outlook report. The report highlights continued leasing activity

Nobel Laureate David Baker is leading a new University of Washington initiative backed by $7 million to develop designer enzymes and proteins for applications in

Just – Evotec Biologics has been awarded a multi-year contract by BARDA to optimize the biomanufacturing of monoclonal antibodies targeting filovirus diseases including Ebola and

Life Science Washington is helping founders strengthen investor messaging while promoting Seattle’s position as a leading hub for AI-driven biotechnology. Marc Cummings highlighted the growing

Sana Biotechnology reported that its donor-derived islet cell therapy continued producing insulin for 14 months in one patient with Type 1 diabetes, with no safety

Vertex reported phase 3 data showing povetacicept significantly reduced proteinuria compared to placebo in immunoglobulin A nephropathy and said it plans to seek FDA approval

To better serve a broader range of entrepreneurs and companies, LSW Institute is now LSW Entrepreneurship & Venture Services, offering a wider range of support